Laurie Toich, Assistant Editor

Alternative payment models for biosimilars and reference products may reduce Part B spending up to 35%.

Diabetes screening tests may be inaccurate, and can lead to over and under treatment.

Restoring gut bacteria could treat patients with IPEX syndrome.

A decrease in a protein associated with depression may increase cancer mortality.

Small molecule inhibitor presents promising treatment option for glioblastoma tumors.

GA11 could be used as a novel treatment option for patients with aggressive glioma.

Coloforsin increased survival in mouse models of Krabbe disease.

Top news of the day from across the healthcare landscape.

Repealing the Affordable Care Act may result in 2.6 million job losses in 2019.

Novel drug from Pfizer treats moderate to severe rheumatoid arthritis that had an inadequate response to methotrexate monotherapy.

Combination therapy to be assessed in multiple myeloma and solid cancers.

New proposed Humira biosimilar performed well in a clinical trial for rheumatoid arthritis.

Opdivo plus Darzalex will be investigated in a new clinical trial.

Novo Nordisk and Glooko will create a digital health solution for diabetes management.

Novo Nordisk and Glooko will create a digital health solution for diabetes management.

Merlin@home Transmitter has shown cybersecurity vulnerabilities.

Individuals lacking educational qualifications had a 150% increased risk of heart attack.

Top news of the day from across the healthcare landscape.

$101 billion was spent on diabetes in 2013, which made it the top health spending category.

Pfizer’s Remicade biosimilar will now be reimbursed by Medicare.

Novartis will collaborate with Ionis Pharmaceuticals and Akcea Therapeutics to develop 2 novel drugs that reduce cardiovascular risks.

Antiviral herpes drug may be able to treat Alzheimer’s disease.

A 30% increase in hemoglobin caused the brain to shrink in patients with multiple sclerosis by 0.1%.

Brain shrinkage in patients with multiple sclerosis may be linked to leaked hemoglobin protein.

Top news of the day from across the healthcare landscape.

Otezla has been found to improve the signs and symptoms of psoriatic arthritis.

Fenofibrate plus statin could provide a novel treatment option for patients with persistant high cholesterol.

Multiple clinical trials of vadastuximab talirine have been placed on clinical hold by the FDA.

Treatment with atezolizumab more than doubled survival compared with chemotherapy.

Modafinil was seen to reduce impulsiveness, which is a major component of food addiction.